Study finds improved quality of life after gender-affirming vaginoplasties

Transfeminine people 18 years and older report significant benefits 12 months post procedure

5:00 AM

Author | Valerie Goodwin

exam table
Jacob Dwyer, Justine Ross, Michigan Medicine

Gender-affirming vaginoplasty is a common genital gender-affirming surgery sought by transfeminine people.

A research team at University of Michigan Health led by Caleb Haley, M.D., an Integrated Plastic Surgery Resident at U-M Health and Fellow in the National Clinician Scholars Program, used data from U-M Health between September 2018 and February 2023 to gain a better understanding of the experiences of people who undergo this procedure.

The study, published in the Annals of Surgery, had inclusion criteria that required individuals to be aged 18 years of age or older, English-speaking, and meeting World Professional Association for Transgender Health, also known as WPATH, standards of care surgical criteria.

Researchers gathered responses from 48 participants and used several instruments to measure their physical and psychosocial well being.

These included measures for depression, anxiety, body image, genital satisfaction, psychosocial functioning, pain, and sexual functioning.

Questionnaires were answered by participants preoperatively, three months postoperatively, and 12 months postoperatively.

Following gender-affirming vaginoplasty, transfeminine individuals reported significant improvements regarding their physical and mental health, body image, and psychosocial functioning.

While minor complications following this procedure were common, they did not negatively impact patients’ subjective outcomes.

Overall, this study shows gender-affirming vaginoplasty is associated with significant quality of life improvements, highlighting the importance of ensuring access to this procedure for transfeminine people.

Additional authors: Cole V. Roblee, M.D., from the Department of Surgery, Swedish Medical Center, Seattle, WA. Gaines Blasdel, B.S., from the University of Michigan Medical School, Ann Arbor, MI, USA. Jennifer B. Hamill, M.P.H., Shelby Svientek, M.D., Lauren Marquette, M.D., Jessica J. Hsu, M.D., Ph.D., Edwin G. Wilkins, M.D., M.S., Megan Lane, M.D., M.S., and William M. Kuzon, M.D., Ph.D., from the Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA. Peter Mankowski, M.D., from the Section of Plastic Surgery, Department of Surgery, University of Calgary, Calgary, Alberta, Canada. Pasithorn A. Suwanabol, M.D., M.S., from the Department of Surgery, University of Michigan, Ann Arbor, MI, USA. Shane D. Morrison, M.D., M.S., from the Division of Plastic Surgery, Department of Surgery and Department of Urology, University of Washington, Seattle, WA, USA

Paper cited: “Gender-Affirming Vaginoplasty Improves Quality of Life in Transfeminine Individuals,” Annals of Surgery. DOI: 10.1097/SLA.0000000000006988

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.


More Articles About:

All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Rachel Upjohn Building groundbreaking ceremony
News Release

How U-M helped bring depression out of the darkness

The history of the founding of the Eisenberg Family Depression Center at the University of Michigan, the nation's first center focused on research, community outreach and stigma reduction in depression and bipolar disorder.
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.